Literature DB >> 20032150

Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.

Onofrio A Catalano1, Garry Choy, Andrew Zhu, Peter F Hahn, Dushyant V Sahani.   

Abstract

PURPOSE: To investigate the utility of diffusion-weighted (DW) imaging in distinguishing bland thrombus from neoplastic thrombus in the portal vein in patients with hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: In this retrospective institutional review board-approved HIPAA-complaint study, the imaging results in 25 patients (16 men [average age, 62.3 years; range, 35-75 years] and nine women [average age, 58.4 years; range, 32-69 years]; overall average age, 60.1 years; range, 32-75 years) with HCC and portal vein thrombosis who were examined with both contrast material-enhanced computed tomography (CT) and 1.5-T magnetic resonance (MR) imaging were reviewed. Axial echo-planar two-dimensional DW imaging was performed by using b values of 50, 400, and 800 sec/mm(2). A thrombus was considered neoplastic if it expanded the vessel or enhanced on the dynamic CT and MR images; otherwise it was considered bland. The signal intensity (SI) of the thrombus and HCC lesions in the same patients was compared on DW images. The results were evaluated by using the Fisher exact test. The apparent diffusion coefficients (ADCs) of HCC and thrombus were used to compute the ratio of the ADC of the thrombus to the ADC of the tumor.
RESULTS: On DW images, 15 of 19 neoplastic thrombi demonstrated same SI and four showed lower SI than the primary HCC. Each of the six bland thrombi had lower SI than the primary HCC (P < .001). The mean ADC of HCC and thrombus in the neoplastic thrombus group was 0.87 x 10(-3) mm(2)/sec and 0.88 x 10(-3) mm(2)/sec, respectively (P = .45). The ADC of the bland thrombus was 2.89 x 10(-3) mm(2)/sec, significantly higher than the ADC of the HCC (1.0 x 10(-3) mm(2)/sec, P < .0003). The ratio of the ADC of the thrombus to the ADC of the tumor in the bland thrombus group was 2.9 compared with 0.998 in the neoplastic group (P = .0003).
CONCLUSION: DW imaging enables discrimination between bland and neoplastic portal vein thrombi when the ratio of the ADC of the thrombus to the ADC of HCC was lower than 2 and when the thrombi showed similar SI as the primary HCC when qualitative analysis was performed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20032150     DOI: 10.1148/radiol.09090304

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  51 in total

Review 1.  Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis.

Authors:  William A Moore; Gaurav Khatri; Ananth J Madhuranthakam; Robert D Sims; Ivan Pedrosa
Journal:  AJR Am J Roentgenol       Date:  2014-05       Impact factor: 3.959

Review 2.  Cross-sectional imaging of congenital and acquired abnormalities of the portal venous system.

Authors:  Mustafa Özbayrak; Servet Tatlı
Journal:  Diagn Interv Radiol       Date:  2016 Nov-Dec       Impact factor: 2.630

3.  Liver Transplantation for a Patient with Hepatocellular Carcinoma with Vascular Invasion and Exceeding Milan Criteria-Happy End Despite it all.

Authors:  R Rozen; Y Menachem; B I Carr; O Shibolet
Journal:  J Gastrointest Cancer       Date:  2018-06

Review 4.  Acute Portal Vein Thrombosis: Current Trends in Medical and Endovascular Management.

Authors:  Stephen M Seedial; Samdeep K Mouli; Kush R Desai
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

Review 5.  Infiltrating hepatocellular carcinoma: seeing the tree through the forest.

Authors:  Aram Demirjian; Peter Peng; Jean-Francois H Geschwind; David Cosgrove; Jacob Schutz; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2011-07-02       Impact factor: 3.452

6.  Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study.

Authors:  Li Jun Qian; Jiong Zhu; Zhi Guo Zhuang; Qiang Xia; Yu Fan Cheng; Jian Ying Li; Jian Rong Xu
Journal:  Eur Radiol       Date:  2012-05-24       Impact factor: 5.315

Review 7.  Tumor thrombus: incidence, imaging, prognosis and treatment.

Authors:  Keith Bertram Quencer; Tamir Friedman; Rahul Sheth; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 8.  MRI of hepatocellular carcinoma: an update of current practices.

Authors:  Hina Arif-Tiwari; Bobby Kalb; Surya Chundru; Puneet Sharma; James Costello; Rainner W Guessner; Diego R Martin
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

9.  Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors.

Authors:  Laura Prakash; Jeffrey E Lee; James Yao; Priya Bhosale; Aparna Balachandran; Huamin Wang; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2015-08-18       Impact factor: 3.452

Review 10.  Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.

Authors:  Luciano Tarantino; Pasquale Ambrosino; Matteo Nicola Dario Di Minno
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.